Sodium phosphate monobasic monohydrate/sodium phosphate dibasic anhydrous tablets (OsmoPrep, Salix) were approved by FDA for cleansing of the colon prior to colonoscopy in patients aged 18 years or older.
Sodium phosphate monobasic monohydrate/sodium phosphate dibasic anhydrous tablets (OsmoPrep, Salix) were approved by FDA for cleansing of the colon prior to colonoscopy in patients aged 18 years or older.
FDA approved omeprazole/sodium bicarbonate (Zegerid, Santarus), an immediate-release proton pump inhibitor (PPI), for the short-term treatment of active duodenal ulcers and erosive esophagitis diagnosed by endoscopy, the short-term treatment of active benign gastric ulcers, the maintenance of healing of erosive esophagitis, and for heartburn and other symptoms associated with gastroesophageal reflux disease (GERD).
FDA and EMA Accepts Applications for New Nusinersen Regimen
January 23rd 2025An investigational higher dose of spinal muscular atrophy drug nusinersen gains attention as the FDA and European Medicines Agency (EMA) considerate it as an alternative than the current lower FDA-approved dosage.
Read More